Subject: Submission deadline extended to September 30, 2022Dear all,
We are pleased to announce an updated submission deadline for the call for manuscripts for a special issue of Statistics in Biopharmaceutical Research (SBR), an Official Journal of the American Statistical Association, motivated by the 2021 Workshop of the NISS Ingram Olkin Forum on Randomization Tests to Address Clinical Trial Disruptions.
Members of the NISS Ingram Olkin Forum on Randomization Tests to Address Clinical Trial Disruptions, the members of the randomization working group, and the general scientific community are invited to apply. The paper must focus on topics related to randomization in clinical trials. Submissions pertaining to the use of randomization to address clinical trial disruptions are welcome. Manuscripts should be submitted online at ScholarOne Manuscripts System
https://mc.manuscriptcentral.com/statsbr. Once you login to the system, go to the "Start New Submission" page. Please select "RRDART" at "Step 1: Type, Title, & Abstract".
Manuscripts can be submitted until September 30, 2022. Pleases note that there is no guarantee of acceptance for a submission. All papers will be peer-reviewed, according to the reviewing principles of SBR. Accepted papers will be published continuously online on the journal website (as soon as accepted) and will be listed together in the special issue.
A guide for authors and other relevant information for submission of manuscripts is available on the "Instructions for Authors" page at the journal website
https://www.tandfonline.com/toc/usbr20/current and "ASA Style Guide" page at ASA-Tayler and Francis website
https://amstat.tfjournals.com/asa-style-guide/ Manuscripts are accepted in Word or LaTeX, though LaTeX is preferred. The LaTeX template is available here:
https://www.tandfonline.com/action/authorSubmission?journalCode=usbr20&page=instructionsIf you have any questions, please do not hesitate to reach out to Diane Uschner (
duschner@bsc.gwu.edu), Oleksandr Sverdlov (
alex.sverdlov@novartis.com), Jonathan Chipman (
Jonathan.Chipman@hci.utah.edu) or Toshimitsu Hamasaki (
thamasaki@gwu.edu, Editor of Statistics in Biopharmaceutical Research).
Best regards,
Diane Uschner, Jonathan Chipman, Oleksandr Sverdlov, and Bill Rosenberger
Guest Associate Editors for the Special Issue on Randomization in Clinical Trials
------------------------------
Diane Uschner
George Washington University
------------------------------
Original Message:
Sent: 01-07-2022 08:58
From: Diane Uschner
Subject: Special Issue on Randomization - Statistics in Biopharmaceutical Research
Dear all,
we are delighted about the interest in the Special Issue and would like to thank all of those who reached out to us via e-mail. We want to clarify that contributions need to focus on randomization. It is not required that contributions address the topic of clinical trial disruptions.
Please do not hesitate to reach out with additional questions.
Kind regards
------------------------------
Diane Uschner
George Washington University
Original Message:
Sent: 01-03-2022 15:04
From: Diane Uschner
Subject: Special Issue on Randomization - Statistics in Biopharmaceutical Research
Dear all,
We are pleased to announce a call for manuscripts for a special issue of Statistics in Biopharmaceutical Research (SBR), an Official Journal of the American Statistical Association, motivated by the 2021 Workshop of the NISS Ingram Olkin Forum on Randomization Tests to Address Clinical Trial Disruptions.
Members of the NISS Ingram Olkin Forum on Randomization Tests to Address Clinical Trial Disruptions, the members of the randomization working group, and the general scientific community are invited to apply. The paper must focus on topics related to randomization in clinical trials. Submissions pertaining to the use of randomization to address clinical trial disruptions are welcome.
Manuscripts should be submitted online at ScholarOne Manuscripts System https://mc.manuscriptcentral.com/statsbr. Once you login to the system, go to the "Start New Submission" page. Please select "RRDART" at "Step 1: Type, Title, & Abstract". Manuscripts can be submitted until March 31, 2022. Pleases note that there is no guarantee of acceptance for a submission. All papers will be peer-reviewed, according to the reviewing principles of SBR. Accepted papers will be published continuously online on the journal website (as soon as accepted) and will be listed together in the special issue.
A guide for authors and other relevant information for submission of manuscripts is available on the "Instructions for Authors" page at the journal website https://www.tandfonline.com/toc/usbr20/current and "ASA Style Guide" page at ASA-Tayler and Francis website https://amstat.tfjournals.com/asa-style-guide/
Manuscripts are accepted in Word or LaTeX, though LaTeX is preferred. The LaTeX template is available here: https://www.tandfonline.com/action/authorSubmission?journalCode=usbr20&page=instructions
If you have any questions, please do not hesitate to reach out to Diane Uschner (duschner@bsc.gwu.edu), Oleksandr Sverdlov (alex.sverdlov@novartis.com), Jonathan Chipman (Jonathan.Chipman@hci.utah.edu) or Toshimitsu Hamasaki (thamasaki@gwu.edu, Editor of Statistics in Biopharmaceutical Research).
Best regards,
Diane Uschner, Jonathan Chipman, Oleksandr Sverdlov, and Bill Rosenberger
Guest Associate Editors for the Special Issue on Randomization in Clinical Trials
------------------------------
Diane Uschner
George Washington University
------------------------------